TXNDC4 Polyclonal Antibody, APC-Cy7 Conjugated
Cat# bs-10507R-APC-Cy7
Size : 100ul
Brand : Bioss
TXNDC4 Polyclonal Antibody, APC-Cy7 Conjugated
Applications
Reactivity
Overview | |
Catalog # | bs-10507R-APC-Cy7 |
Product Name | TXNDC4 Polyclonal Antibody, APC-Cy7 Conjugated |
Applications | IF(ICC) |
Reactivity | Human, Mouse, Rat |
Specifications | |
Conjugation | APC-Cy7 |
Host | Rabbit |
Source | KLH conjugated synthetic peptide derived from human TXNDC4 |
Immunogen Range | 51-150/406 |
Clonality | Polyclonal |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein A. |
Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Storage Condition | Store at -20¡C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target | |
Gene ID | 23071 |
Swiss Prot | Q9BS26 |
Synonyms | Endoplasmic reticulum resident protein 44; Endoplasmic reticulum resident protein 44 kDa; Endoplasmic reticulum resident protein ERp44; ER protein 44; ERP44; KIAA0573; PDIA10; Protein disulfide isomerase family A, member 10; Thioredoxin domain containing 4 (endoplasmic reticulum); Thioredoxin domain containing protein 4; UNQ532/PRO1075; ERP44; ERP44_HUMAN. |
Background | Mediates thiol-dependent retention in the early secretory pathway, forming mixed disulfides with substrate proteins through its conserved CRFS motif. Inhibits the calcium channel activity of ITPR1. May have a role in the control of oxidative protein folding in the endoplasmic reticulum. Required to retain ERO1L and ERO1LB in the endoplasmic reticulum. |
Application Dilution | |
IF(ICC) | 1:50-200 |